https://www.statnews.com/2021/06/29/biogen-fda-alzheimers-drug-approval-aduhelm-project-onyx/
How Biogen used an FDA back channel to win Alzheimer's drug approval
Jul 31, 2023 - When Aduhelm’s prospects appeared dead, Biogen mounted a secret campaign to resurrect the drug and convince the FDA to approve it.
biogenusedfdabackchannel
https://www.statnews.com/2026/03/30/biotech-news-biogen-lupus-drug-improves-skin-clearance-in-trial/
Biogen lupus drug improves skin clearance in mid-stage study | STAT
Mar 30, 2026 - Today's biotech news covers a positive mid-stage study for Biogen lupus drug, Takeda's competitive Phase 3 psoriasis data, and more.
biogenlupusdrugskinclearance
https://www.juve-patent.com/cases/biogen-is-entitled-to-damages-in-tecfidera-case-rules-regional-court-hamburg/
Biogen is entitled to damages in Tecfidera case rules Regional Court Hamburg
Apr 28, 2026 - Biogen can claim damages from Viatris for selling dimethyl fumarate generic before the end of Tecfidera's market exclusivity.
biogendamagescaserulesregional